TARGETING OPIOID NEUROTRANSMISSION IN BORDERLINE PERSONALITY DISORDER WITH SELF-HARMING BEHAVIOR: A [11C]-NOP-1A POSITRON EMISSION TOMOGRAPHY STUDY

Registry ID

CAMHPET-CTA-135

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

CENTRE FOR ADDICTION AND MENTAL HEALTH

Start date

2023-01-11

Last update

2023-01-03

Conditions

• PERSONALITY DISORDER

Related clinical trials

• COMBINING KETAMINE WITH DIALECTICAL BEHAVIOURAL THERAPY (DBT) FOR SUICIDALITY IN INDIVIDUALS WITH TREATMENT RESISTANT DEPRESSION AND BORDERLINE PERSONALITY DISORDER: A PHASE II RANDOMIZED, MIDAZOLAM-CONTROLLED CLINICAL TRIAL (KET-DBT)

View on source registry